Cooper Companies Raised to Buy at Jefferies on Valuation Disconnect
Johnson & Johnson Q2 Earnings Preview: Can New Drugs Lift Sagging Stock?
Jefferies Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $105
Jefferies Gives a Buy Rating to Alcon (ALC)
The Zacks Analyst Blog DexCom, Hologic, Alcon Intuitive Surgical and Thermo Fisher Scientific
Morgan Stanley Cuts STAAR to Underweight, Cites Growth Expectations
Medical Technology Companies Poised for Another 'Solid' Quarter, Morgan Stanley Says
Alcon (ALC) Rides on Innovation, Balanced Segmental Sales
Express News | Alcon Inc : Morgan Stanley Raises to Equal-Weight
Express News | Alcon Inc : Morgan Stanley Raises Target Price to $85.00 From $65.00
Buy 5 Medical Devices Stocks to Enhance Your Portfolio in 2H
BTIG Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $96
Express News | Alcon AG : Btig Raises Target Price to $96 From $92
Morgan Stanley Upgrades Alcon to Equalweight From Underweight, Raises Price Target to $85 From $65
Express News | Needham Reiterates Buy on Alcon, Maintains $101 Price Target
Alcon Analyst Ratings
STAAR Surgical Gains Amid Takeover Speculation
Wells Fargo Maintains Alcon(ALC.US) With Buy Rating, Maintains Target Price $94
UBS Maintains Alcon(ALC.US) With Buy Rating, Raises Target Price to $102.68
UBS Sticks to Its Buy Rating for Alcon (ALC)